Biotechnology

A trial to test Stem Cells as the Macular Dystrophy Stargardt's end-of-life care Federal officials have again been approved through the use of human embryonic stem cells--currently, only the second seeks to deal with the rare disease that causes blindness of young clinical research. Advanced cell technology, biotechnology company has its registered office or place of Marlborough, mass., said today that it received the green light of the u.s. food and drug administration; at the beginning of the investigation, the company expects to begin next year 12 patients diagnosed Macular Dystrophy Stargardt 's. Condition, which is at present an incurable, destroys the progressive Vision is about 10 at the beginning of the age. Researchers to Inject 50 000 and 200 000 healthy Retinal cells derived from embryonic stem cells into account between each patient's eyes; -animal cells helped prevent Vision loss and returns some in sight. "I think this marks the beginning of a new era fo...